Econate VT150 mg

Econazole nitrate is a broad-spectrum imidazole antifungal used topically to treat a range of fungal and yeast infections of the skin. It is indicated for:

Dermatophyte (Ringworm-type) Infections

• Tinea corporis ringworm of the body, presenting as itchy, ring-shaped red patches
• Tinea cruris jock itch, a fungal infection of the groin and inner thighs
• Tinea pedis athlete's foot, affecting the skin between the toes and soles
• Tinea manuum fungal infection of the hands
• Tinea capitis (scalp involvement, in some formulations, under medical supervision)

Yeast Infections

• Cutaneous candidiasis skin infection caused by Candida species, common in skin folds and moist areas
• Candidal intertrigo and diaper (napkin) dermatitis with candidal involvement

Other Fungal Skin Conditions

• Pityriasis (tinea) versicolor a common, patchy skin discoloration caused by Malassezia yeast

Econazole nitrate treats only fungal and yeast infections; it is not effective against bacterial or viral skin conditions, and a doctor's diagnosis is recommended if the cause of a skin rash is uncertain.

Contains Econate VT 150 mg 1% as the active ingredient in a topical cream base. Some markets also offer Econate VT 150 mg as a lotion or, for vaginal candidiasis, as a pessary/vaginal cream; this entry covers the topical skin (dermatological) cream. Confirm the specific product's formulation and strength on its own label, since vaginal and dermatological formulations are not interchangeable.

Econazole nitrate is a topical antifungal cream from the imidazole class, used to clear fungal and yeast infections affecting the skin, such as ringworm, athlete's foot, jock itch, and cutaneous candidiasis. It works by damaging the fungal cell membrane, which stops the fungus from growing and eventually kills it. Econazole is applied directly to the affected skin once or twice daily and is generally well tolerated, with treatment courses typically lasting 2 to 4 weeks depending on the site and severity of infection.

Therapeutic Class: Topical Antifungal

Econazole nitrate has broad-spectrum activity against dermatophytes (such as Trichophyton, Microsporum, and Epidermophyton species), yeasts (including Candida albicans and Malassezia furfur), and, to a lesser extent, some gram-positive bacteria. After topical application, econazole penetrates the stratum corneum and underlying epidermis, with only minimal systemic absorption through intact skin, which is why systemic side effects are rare with normal topical use.

• Wash and dry the affected area thoroughly before application
• Apply a thin layer of cream and gently massage it into the skin until absorbed
• Wash hands after application, unless the hands are the area being treated
• For tinea pedis, pay particular attention to the skin between the toes, and consider keeping the feet dry and well-ventilated (breathable footwear, cotton socks) to support treatment
• Continue treatment for the full recommended duration, even after visible symptoms clear

Because systemic absorption from topical econazole is minimal, clinically significant systemic drug interactions are uncommon with normal use on limited areas of intact skin. The following points are still worth noting:

• Use over large areas of broken or denuded skin: systemic absorption may be increased, which could theoretically raise the risk of interactions relevant to systemic azole antifungals (such as effects on drugs metabolized by CYP3A4); this is a much lower risk with topical use than with oral azole antifungals, but caution is reasonable with extensive application.
• Other topical products applied to the same area: combining econazole with other topical medicines on the same skin site should be discussed with a pharmacist, since layering products can affect absorption and local tolerability.

Common side effects

• Local burning or stinging sensation on application
• Itching
• Redness at the application site

Less common side effects

• Allergic contact dermatitis a localized allergic skin reaction to the cream itself
• Skin peeling or irritation

Discontinue use and consult a doctor if signs of a worsening reaction develop, such as spreading redness, blistering, or increasing discomfort, since this may indicate irritation or an allergic reaction to the product rather than the underlying infection.

Pregnancy

Topical econazole is associated with minimal systemic absorption when used as directed on limited areas of skin. It has been widely used in pregnancy without evidence of harm at the low systemic exposure achieved with topical use, but as with any medicine, use during pregnancy should be discussed with a doctor, particularly if applied over large areas or to broken skin.

Breastfeeding

Given the low systemic absorption from topical use, econazole is generally considered compatible with breastfeeding when applied away from the breast area; discuss with a healthcare professional if in doubt.

• For external (skin) use only avoid contact with the eyes, mouth, nose, or vaginal area, unless a specific product is formulated for that use; if accidental eye contact occurs, rinse thoroughly with water.
• Complete the full course stopping treatment early, once symptoms improve, is a common reason for fungal infections to recur; continue for the full recommended duration.
• Extensive or broken skin use with caution over large areas of damaged or broken skin, since this may increase systemic absorption.
• Diagnosis uncertainty if the rash does not look like a typical fungal infection, or fails to improve, see a doctor to confirm the diagnosis before continuing self-treatment.

Topical overdose is unlikely with normal use on limited skin areas, since systemic absorption is minimal. If the cream is accidentally swallowed, mild gastrointestinal upset (nausea, vomiting) may occur; contact a doctor or poison control center for advice if a significant amount is ingested, particularly by a child. Excessive or prolonged application to the skin may increase local irritation; if this occurs, discontinue use and consult a doctor.

Store the cream at room temperature, generally below 25-30°C, away from direct sunlight and excessive heat, with the cap tightly closed after use to prevent drying out or contamination. Keep out of reach of children. Do not use after the expiry date printed on the packaging.

• Infants and young children: Used for candidal diaper dermatitis and other pediatric fungal skin infections under medical guidance; apply sparingly and avoid occlusive dressings unless directed, since infant skin may absorb topical medicines more readily than adult skin.
• Elderly: No specific dose adjustment is generally required for topical use.
• Diabetic patients: May be more prone to recurrent candidal skin infections; good blood glucose control supports treatment success alongside topical antifungal therapy.

Treatment duration depends on the specific fungal condition, typically ranging from 2 weeks (ringworm, jock itch, versicolor) to up to 4 weeks for athlete's foot, as shown in the dosage table. Medical review is advised if there is no improvement within the expected timeframe, or if symptoms recur shortly after stopping treatment.

Drug Class: Imidazole antifungal

Econazole works by inhibiting the enzyme lanosterol 14-alpha-demethylase, which fungal cells need to produce ergosterol, an essential structural component of the fungal cell membrane. Without adequate ergosterol, the fungal cell membrane becomes unstable and leaky, which disrupts fungal growth and eventually causes the fungal cell to die. This mechanism is shared broadly across the imidazole antifungal class.

Econazole nitrate cream is used in infants and children for fungal skin infections, including candidal diaper dermatitis, following the same general dosing pattern as adults, applied sparingly to the affected area. Parents should consult a doctor or pharmacist before treating a young child, particularly an infant, to confirm the diagnosis and appropriate duration of use.